372 filings
Page 4 of 19
6-K
ddypxvut3dr9zx
3 Apr 23
Current report (foreign)
8:07am
6-K
f4zhjyc
28 Mar 23
BioNTech Announces New ADS Repurchase Program
6:59am
6-K
r3sp1say3
27 Mar 23
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
6:49am
6-K
780ohs4aqk61g r3k
20 Mar 23
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications
8:00am
6-K
pp0 h11e9t
14 Mar 23
Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster
6:12pm
6-K
197j5wzg
1 Mar 23
Current report (foreign)
9:01am
6-K
w9xjje7y3 tot0
24 Feb 23
Current report (foreign)
8:58am
S-8
1xstt8
13 Feb 23
Registration of securities for employees
5:06pm
S-8 POS
mekmswzer2kp
13 Feb 23
Registration of securities for employees (post-effective amendment)
4:04pm
6-K
rh5sd
10 Jan 23
Current report (foreign)
4:04pm
6-K
5sq47glnrlmvhez3so
10 Jan 23
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
9:07am
6-K
mamqobe6u
22 Dec 22
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
8:03am
6-K
fyd7a
9 Dec 22
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation
9:17am
6-K
iiri16 nfo7l72k
8 Dec 22
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
5:27pm
6-K
0q1kuy2j
7 Dec 22
Current report (foreign)
5:39pm
6-K
kynk3nqxs ufewq5ex
5 Dec 22
Current report (foreign)
8:48am
6-K
j6olcukubh5e
30 Nov 22
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
7:51am
6-K
mu14remxm3667rab
18 Nov 22
Current report (foreign)
7:43am
6-K
wyxvzo1e l38ubp19yuj
16 Nov 22
Current report (foreign)
9:56pm